Group 1 - The mercury-containing sphygmomanometers and thermometers will officially cease production starting January 1, 2026, in compliance with China's obligations under the Minamata Convention on Mercury, leading to widespread nostalgia and discussion among the public [1][3] - The transition away from mercury is aimed at promoting environmental protection and health, but raises concerns about the accuracy of electronic blood pressure monitors for the 270 million hypertension patients in China [3][11] - Traditional mercury sphygmomanometers are considered the "gold standard" for blood pressure measurement due to their non-invasive nature and reliability, while electronic devices often use oscillometric methods that may lead to significant measurement errors [5][6] Group 2 - The current electronic blood pressure monitors face challenges in accuracy, especially in patients with irregular heartbeats, which can exacerbate the existing issues of low awareness, treatment, and control rates among hypertension patients in China [11] - Hanwang Technology has developed an innovative electronic sphygmomanometer that incorporates artificial intelligence to replicate the traditional auscultatory method, addressing the limitations of current electronic devices [11][13] - The new device features high-sensitivity sensors, a mechanism that mimics manual pressure control, and an AI system trained on over 1 million quality auscultation data points, marking a significant advancement in blood pressure monitoring technology [13][17] Group 3 - The upcoming ban on mercury sphygmomanometers is part of a broader national initiative to eliminate mercury use, with Hanwang Technology actively participating in this effort through its "Clean Mercury Action" project [15] - The Hanwang auscultatory electronic blood pressure monitor not only provides accurate measurements but also has a high sensitivity of 94.91% for detecting atrial fibrillation, enhancing its role as a comprehensive health management tool for families [17][19] - The year 2026 is seen as the beginning of a new era in precision medicine, moving towards smarter and more comprehensive health monitoring solutions [19]